Back to Search Start Over

Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology.

Authors :
Yaegashi, Hiroko
Hayashi, Yukikazu
Takeda, Makoto
Chiu, Shih-Wei
Nakayama, Haruhiko
Ito, Hiroyuki
Takano, Atsushi
Tsuboi, Masahiro
Teramoto, Koji
Suzuki, Hiroyuki
Kato, Tatsuya
Yasui, Hiroshi
Nagamura, Fumitaka
Daigo, Yataro
Yamaguchi, Takuhiro
Source :
Therapeutic Innovation & Regulatory Science; Nov2024, Vol. 58 Issue 6, p1031-1041, 11p
Publication Year :
2024

Abstract

Background: Clinical trials have become larger and more complex. Thus, eSource should be used to enhance efficiency. This study aimed to evaluate the impact of the multisite implementation of eSource direct data capture (DDC), which we define as eCRFs for direct data entry in this study, on efficiency by analyzing data from a single investigator-initiated clinical trial in oncology. Methods: Operational data associated with the targeted study conducted in Japan was used to analyze time from data occurrence to data entry and data finalization, and number of visits to the site and time spent at the site by clinical research associates (CRAs). Additionally, simulations were performed on the change in hours at the clinical sites during the implementation of eSource DDC. Results: No difference in time from data occurrence to data entry was observed between the DDC and the transcribed data fields. However, the DDC fields could be finalized 4 days earlier than the non-DDC fields. Additionally, although no difference was observed in the number of visits for source data verification (SDV) by CRAs, a comparison among sites that introduced eSource DDC and those that did not showed that the time spent at the site for SDV was reduced. Furthermore, the simulation results indicated that even a small amount of data to be collected or a small percentage of DDC-capable items may lead to greater efficiency when the number of subjects per site is significant. Conclusions: The implementation of eSource DDC may enhance efficiency depending on the study framework and type and number of items to be collected. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
21684790
Volume :
58
Issue :
6
Database :
Supplemental Index
Journal :
Therapeutic Innovation & Regulatory Science
Publication Type :
Academic Journal
Accession number :
180626083
Full Text :
https://doi.org/10.1007/s43441-024-00671-0